Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CLS disposes of two properties in Germany

(Sharecast News) - Property investment firm CLS Holdings said on Tuesday that it has disposed of two properties in Germany for a total of €41.3m. CLS has completed the sale of Techno Centre in Munich, an 8,527 sqm mixed-use office and industrial building, and has also unconditionally exchanged contracts on the sale of Jarrrestrasse 8-10 in Hamburg, a fully let 5,488 sqm office building, with completion set to take place in early August.

The FTSE 250-listed firm said the properties offered limited asset management opportunities and no longer aligned with the forward-looking strategy for its portfolio.

CLS noted that they were sold at a discount of roughly 10% below the 31 December 2024 valuations and at an average net initial yield of 6.4%.

Proceeds from the sale will be used to pay down debt, and with the recent completion of the sale of Spring Mews Student in the UK for £101.1m, CLS's pro-forma loan-to-value ratio will reduce from 50.7% at year-end to 47.0%.

As of 0830 BST, CLS shares were up 3.42% at 72.50p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.